CYTUNE
Live / Registered — Registered (as of 20 Sept 2022)
What this means for you
Registered since 20 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90389015
- Registration number
- 6849176
- Mark type
- Design + words
- Filed
- 17 Dec 2020
- Published for opposition
- 05 Jul 2022
- Registered
- 20 Sept 2022
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of neoplasia, tumors, cancer and infectious diseases; anticancer preparations; antitumor drugs in the nature of tumor suppressing agents; vaccines; anticancer vaccines; pharmaceutical preparations for the treatment of neoplasia, tumors, cancer and infectious diseases, namely, peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical and veterinary purposes; biological preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; cellular preparations for the treatment of neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; radiopharmaceutical preparations for the treatment of neoplasia, tumors and cancer for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; diagnostic agents, preparations and test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neoplasia, tumors, cancer and infectious diseases for medical and veterinary purposes; drug delivery agents; adjuvants for medical use; dietetic substances adapted for medical use
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of biotechnological and pharmaceutical research and development; industrial analysis and research services in the field of biotechnological and pharmaceutical research and development; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases and infectious diseases; pharmaceutical drug development services; conducting clinical trials for others; scientific preclinical and clinical research in the field of prevention and treatment of neoplasia, tumors, cancer and infectious diseases; scientific preclinical and clinical research in the fields of biologics and chemotherapy; analysis of toxicology and mode of action of biological and chemicals and combinations on animals; pharmaceutical and biological product research, development, safety testing, and quality control testing services for others; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services in the nature of computer diagnostic services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management
- Class 044 — Medical, beauty and agricultural services: Medical services; medical diagnostic services
Owner
- Cytune Pharma S.A.S., Nantes, FR
- Cytune Pharma S.A.S., Nantes, FR
- Cytune Pharma S.A.S., Nantes, FR
Prosecution history
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 05 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jul 2022 — PUBLISHED FOR OPPOSITION
- 15 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 May 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED